Combining global and local measures for structure-based druggability predictions - PubMed (original) (raw)
. 2012 Feb 27;52(2):360-72.
doi: 10.1021/ci200454v. Epub 2012 Jan 5.
Affiliations
- PMID: 22148551
- DOI: 10.1021/ci200454v
Combining global and local measures for structure-based druggability predictions
Andrea Volkamer et al. J Chem Inf Model. 2012.
Abstract
Predicting druggability and prioritizing certain disease modifying targets for the drug development process is of high practical relevance in pharmaceutical research. DoGSiteScorer is a fully automatic algorithm for pocket and druggability prediction. Besides consideration of global properties of the pocket, also local similarities shared between pockets are reflected. Druggability scores are predicted by means of a support vector machine (SVM), trained, and tested on the druggability data set (DD) and its nonredundant version (NRDD). The DD consists of 1069 targets with assigned druggable, difficult, and undruggable classes. In 90% of the NRDD, the SVM model based on global descriptors correctly classifies a target as either druggable or undruggable. Nevertheless, global properties suffer from binding site changes due to ligand binding and from the pocket boundary definition. Therefore, local pocket properties are additionally investigated in terms of a nearest neighbor search. Local similarities are described by distance dependent histograms between atom pairs. In 88% of the DD pocket set, the nearest neighbor and the structure itself conform with their druggability type. A discriminant feature between druggable and undruggable pockets is having less short-range hydrophilic-hydrophilic pairs and more short-range lipophilic-lipophilic pairs. Our findings for global pocket descriptors coincide with previously published methods affirming that size, shape, and hydrophobicity are important global pocket descriptors for automatic druggability prediction. Nevertheless, the variety of pocket shapes and their flexibility upon ligand binding limit the automatic projection of druggable features onto descriptors. Incorporating local pocket properties is another step toward a reliable descriptor-based druggability prediction.
Similar articles
- Structure-based druggability assessment--identifying suitable targets for small molecule therapeutics.
Fauman EB, Rai BK, Huang ES. Fauman EB, et al. Curr Opin Chem Biol. 2011 Aug;15(4):463-8. doi: 10.1016/j.cbpa.2011.05.020. Epub 2011 Jun 23. Curr Opin Chem Biol. 2011. PMID: 21704549 Review. - Understanding and predicting druggability. A high-throughput method for detection of drug binding sites.
Schmidtke P, Barril X. Schmidtke P, et al. J Med Chem. 2010 Aug 12;53(15):5858-67. doi: 10.1021/jm100574m. J Med Chem. 2010. PMID: 20684613 - DrugPred: a structure-based approach to predict protein druggability developed using an extensive nonredundant data set.
Krasowski A, Muthas D, Sarkar A, Schmitt S, Brenk R. Krasowski A, et al. J Chem Inf Model. 2011 Nov 28;51(11):2829-42. doi: 10.1021/ci200266d. Epub 2011 Oct 13. J Chem Inf Model. 2011. PMID: 21995295 - Form follows function: shape analysis of protein cavities for receptor-based drug design.
Weisel M, Proschak E, Kriegl JM, Schneider G. Weisel M, et al. Proteomics. 2009 Jan;9(2):451-9. doi: 10.1002/pmic.200800092. Proteomics. 2009. PMID: 19142949 - Druggable pockets and binding site centric chemical space: a paradigm shift in drug discovery.
Pérot S, Sperandio O, Miteva MA, Camproux AC, Villoutreix BO. Pérot S, et al. Drug Discov Today. 2010 Aug;15(15-16):656-67. doi: 10.1016/j.drudis.2010.05.015. Epub 2010 Jun 4. Drug Discov Today. 2010. PMID: 20685398 Review.
Cited by
- Structure of the mycosin-1 protease from the mycobacterial ESX-1 protein type VII secretion system.
Solomonson M, Huesgen PF, Wasney GA, Watanabe N, Gruninger RJ, Prehna G, Overall CM, Strynadka NC. Solomonson M, et al. J Biol Chem. 2013 Jun 14;288(24):17782-90. doi: 10.1074/jbc.M113.462036. Epub 2013 Apr 25. J Biol Chem. 2013. PMID: 23620593 Free PMC article. - The Entamoeba histolytica Vps26 (EhVps26) retromeric protein is involved in phagocytosis: Bioinformatic and experimental approaches.
Martínez-Valencia D, Bañuelos C, García-Rivera G, Talamás-Lara D, Orozco E. Martínez-Valencia D, et al. PLoS One. 2024 Aug 8;19(8):e0304842. doi: 10.1371/journal.pone.0304842. eCollection 2024. PLoS One. 2024. PMID: 39116045 Free PMC article. - Fragment library screening by X-ray crystallography and binding site analysis on thioredoxin glutathione reductase of Schistosoma mansoni.
de Souza Neto LR, Montoya BO, Brandão-Neto J, Verma A, Bowyer S, Moreira-Filho JT, Dantas RF, Neves BJ, Andrade CH, von Delft F, Owens RJ, Furnham N, Silva-Jr FP. de Souza Neto LR, et al. Sci Rep. 2024 Jan 18;14(1):1582. doi: 10.1038/s41598-024-52018-2. Sci Rep. 2024. PMID: 38238498 Free PMC article. - The druggable genome: Twenty years later.
Radoux CJ, Vianello F, McGreig J, Desai N, Bradley AR. Radoux CJ, et al. Front Bioinform. 2022 Sep 30;2:958378. doi: 10.3389/fbinf.2022.958378. eCollection 2022. Front Bioinform. 2022. PMID: 36304325 Free PMC article. - Identification of a new class of proteasome inhibitors based on a naphthyl-azotricyclic-urea-phenyl scaffold.
Allardyce D, Adu Mantey P, Szalecka M, Nkwo R, Loizidou EZ. Allardyce D, et al. RSC Med Chem. 2023 Feb 6;14(3):573-582. doi: 10.1039/d2md00404f. eCollection 2023 Mar 22. RSC Med Chem. 2023. PMID: 36970145 Free PMC article.
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Other Literature Sources